Lamotrigine and Oxcarbazepine drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among 1,637 people who take Lamotrigine and Oxcarbazepine. Common interactions include normal newborn among females, and drug ineffective among males.
The phase IV clinical study analyzes what interactions people who take Lamotrigine and Oxcarbazepine have. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
1,637 people who take Lamotrigine and Oxcarbazepine together, and have interactions are studied.
What is Lamotrigine?
Lamotrigine has active ingredients of lamotrigine. It is used in bipolar disorder. Currently, eHealthMe is studying from 71,357 Lamotrigine users.
What is Oxcarbazepine?
Oxcarbazepine has active ingredients of oxcarbazepine. It is used in epilepsy. Currently, eHealthMe is studying from 14,187 Oxcarbazepine users.
Number of Lamotrigine and Oxcarbazepine reports submitted per year:
Lamotrigine and Oxcarbazepine drug interactions by gender *:
Lamotrigine and Oxcarbazepine drug interactions by age *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Lamotrigine and Oxcarbazepine?
Personalize this study to your gender and ageHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Alonso-Navarro H, Montes JM, Plaza-Nieto JF, Jiménez-Jiménez FJ, "Cataplexy Possibly Associated With Lamotrigine", Journal of clinical psychopharmacology, 2016 Aug .
- Gupta MC, Khanna J, Mathur R, Mittal N, "Lamotrigine-induced fulminant hepatic failure: an unusual presentation", IMSEAR, 2015 Jan .
Related studies
Drug side effects by duration, gender and age:
- Lamotrigine side effects (71,357 reports)
- Oxcarbazepine side effects (14,187 reports)
Common Lamotrigine drug interactions:
- Lamotrigine and Levetiracetam: 6,562 reports
- Lamotrigine and Clonazepam: 6,040 reports
- Lamotrigine and Topiramate: 4,172 reports
- Lamotrigine and Gabapentin: 3,998 reports
- Lamotrigine and Valproic acid: 3,744 reports
- Lamotrigine and Carbamazepine: 3,477 reports
- Lamotrigine and Sertraline: 3,206 reports
- Lamotrigine and Omeprazole: 3,131 reports
- Lamotrigine and Loraz: 3,034 reports
- Lamotrigine and Lorazepam: 2,765 reports
Browse interactions between Lamotrigine and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Oxcarbazepine drug interactions:
- Oxcarbazepine and Levetiracetam: 2,298 reports
- Oxcarbazepine and Topiramate: 1,630 reports
- Oxcarbazepine and Gabapentin: 1,592 reports
- Oxcarbazepine and Clonazepam: 1,266 reports
- Oxcarbazepine and Valproic acid: 1,101 reports
- Oxcarbazepine and Clobazam: 1,001 reports
- Oxcarbazepine and Carbamazepine: 987 reports
- Oxcarbazepine and Omeprazole: 982 reports
- Oxcarbazepine and Lacosamide: 940 reports
Browse interactions between Oxcarbazepine and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on lamotrigine and oxcarbazepine (the active ingredients of Lamotrigine and Oxcarbazepine, respectively), and Lamotrigine and Oxcarbazepine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Lamotrigine and Oxcarbazepine.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Cefdinir and Zantac drug interaction - 2 seconds ago
- Otezla and Norflex drug interaction - 33 seconds ago
- Claravis and Bronchitis - 46 seconds ago
- Celebrex and Attention Deficit/Hyperactivity Disorder - 46 seconds ago
- Celebrex and Attention Deficit Hyperactivity Disorder - 46 seconds ago
- Micafungin and Red Blood Cell Count Decreased - 51 seconds ago
- Hydroxyzine Pamoate and Diclofenac drug interaction - a minute ago
- Amoxicillin and Tagamet Hb drug interaction - a minute ago
- Glyburide and Prostate Cancer - a minute ago
- Testosterone Cypionate and Viagra drug interaction - a minute ago